Rongyi Cao
Overview
Explore the profile of Rongyi Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao L, Sun L, Kong D, Cao R, Guo Z, Guo D, et al.
Ann Hematol
. 2024 Nov;
104(1):489-501.
PMID: 39607486
B-cell acute lymphocytic leukemia (B-ALL) is a malignant proliferative B-lymphocyte disease. Although the outcome of B-ALL has greatly improved with combined chemotherapy, immunotherapy, and hematopoietic stem cell transplantation, some patients...
2.
Jin Y, Zhai M, Cao R, Yu H, Wu C, Liu Y
Curr Pharm Des
. 2023 Nov;
29(42):3408-3420.
PMID: 37936452
Introduction: Breast cancer has emerged as the most widespread cancer globally surpassing lung cancer, and has become a primary cause of mortality among women. While MFHAS1 has been implicated in...
3.
Jing H, Xie R, Bai Y, Duan Y, Sun C, Wang Y, et al.
Front Pharmacol
. 2021 Nov;
12:755653.
PMID: 34803698
Astragaloside IV (AS-IV) has been used to treat cardiovascular disease. However, whether AS-IV exerts a protective effect against hypertensive heart disease has not been investigated. This study aimed to investigate...
4.
Wang Y, Cao R, Yang W, Qi B
J Cell Physiol
. 2019 Jan;
234(8):14319-14329.
PMID: 30652310
Cardiac hypertrophy (CH) has become a huge threat to human health. Recent years, long noncoding RNAs (lncRNAs) have been studied in human diseases, including CH. According to bioinformatics analysis, 10...
5.
Zhang Y, Li H, Cao R, Sun L, Wang Y, Fan S, et al.
Oncotarget
. 2017 Oct;
8(38):64114-64128.
PMID: 28969056
Inactivation of Dickkopf-3 (DKK3) is closely associated with a poor prognosis in various solid tumor and hematologic malignancies. Promoter hypermethylation is one potential cause of DKK3 inactivation. However, whether other...
6.
Li H, Kong X, Cui G, Ren C, Fan S, Sun L, et al.
Int J Hematol
. 2015 Sep;
102(5):558-68.
PMID: 26362858
The aim of the present study was to investigate the effects of rapamycin and its underlying mechanisms on acute lymphoblastic leukemia (ALL) cells. We found that the p14, p15, and...